Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • maa1024
    Junior Member
    • Jan 2018
    • 2

    Optimizing a ddRADSeq study with a large genome

    I am designing a study to investigate the population genetic structure of an endangered species. We've decided to go the ddRADSeq route, and I have a few questions for anyone who has experience with this sequencing method and/or population genetics.

    My species has a large genome (~2Gb), and because I'm assessing change across the entirety of North America over a span of 100 years, I also have a large sample size (n=480).

    In order to maintain a higher level of coverage (25x) while also remaining within the current budget, we can only target 0.25% (5 million bases) of the genome.

    I was hoping for some insight on this issue. Although low, is 0.25% (and 5 million bases) of the genome per individual enough to answer questions regarding population genetic structure with that many individuals at that level of coverage? Or would it be prudent to reduce the amount of coverage in order to include more of the genome?

    Relevant points: 1. No reference genome for this species, but there is one for a closely related species. 2. Very little is known about this species and no population genetics study has been conducted to compare to.
  • Gopo
    Member
    • Nov 2013
    • 41

    #2
    If I understand you correctly, your samples could be up to 100 years old? Depending on the source of DNA, the DNA maybe sheared and low molecular weight, making it less amenable to ddRAD. If this is the case, one can do an initial ddRAD with high quality DNA samples and develop probes/baits to capture the variable RAD loci. Such target enrichment/sequence capture of the "RADnome" would be amenable for degraded DNA samples. See https://www.ncbi.nlm.nih.gov/pubmed/27416967 for more details on the idea of capturing the RADnome.

    Comment

    • maa1024
      Junior Member
      • Jan 2018
      • 2

      #3
      Thank you for the suggestion! The age of a few of my samples is a concern, but they do not make up the bulk of my sample size. This is certainly something I should look into either way.

      Do you have any suggestions regarding the balance between sample size, coverage, and percent of genome?

      Comment

      • Gopo
        Member
        • Nov 2013
        • 41

        #4
        Unfortunately, I can't really give too much advice about optimizing. Others on the forum have more experience than I do. I've personally subsampled a dataset of 16 individuals, 4 per population, genotyped at 20,000 SNPs down to ~100 random SNPs and have gotten very similar pairwise FST, observed and expected heterozygosity, allelic richness, and STRUCTURE results between the 20,000 SNP and 100 SNP datasets. But results will definitely vary, especially for species of conservation concern.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM
        • GATTACAT
          Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
          by GATTACAT
          Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
          07-01-2026, 11:43 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-07-2026, 11:05 AM
        0 responses
        34 views
        0 reactions
        Last Post SEQadmin2  
        Working...